CXCR3/CCR1 antagonists (Millennium/Kyowa)

N/A

Report date: 2025/03/18 20:00:05
NME

Base Information

Drug NameCXCR3/CCR1 antagonists (Millennium/Kyowa)
Drug Alias NameCCR1 antagonist (LeukoSite)CXCR3 antagonist (Millennium/Kyowa)CXCR3 antagonists (LeukoSite)CCR1 antagonist (Millennium/Kyowa)CXCR3/CCR1 antagonists (LeukoSite)
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionC-X-C motif chemokine receptor 3 antagonistsC-C chemokine receptor type 1 antagonists
TargetsC-X-C motif chemokine receptor 3C-C chemokine receptor type 1
Therapy Area/IndicationsPsoriasisCoronary RestenosisMultiple Sclerosis +[4] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesJapan
CombinationsNo
Global Highest StatusDiscontinued (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesLeukosite
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesLeukositeMillennium Pharmaceuticals IncKyowa Hakko Kogyo Co Ltd
Active IndicationsN/A
Inactive IndicationsPsoriasisCoronary RestenosisMultiple Sclerosis +[4] 

Other Information

ATC CodeN/A
Related LinksN/A